MENU
MNPR
AS OF
Dec 26, 04:59 PM (EDT)
Price
$68.66
Change
-$2.12 (-3.00%)
Capitalization
472.99M
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
MNPR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Monopar Therapeutics (MNPR) Ownership - Who owns Monopar Therapeutics?

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
1000 Skokie Boulevard
Phone
+1 847 388-0349
Employees
10
Web
https://www.monopartx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
472.99M
P/E Ratio
N/A
Total Cash
143.68M
Projected Growth
N/A
Total Debt
70.88K
Revenue
N/A
Risk (Beta)
2.26
Dividend Yield
N/A
Total Cash/Share
21.50
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

MNPR
Capitalization
473M
P/E Ratio
N/A
Risk (Beta)
2.26
Dividend Yield
N/A
Total Cash
144M
Total Cash/Share
21.50
Total Debt
70.9K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
142M
P/B Ratio
3.34
Cash Flow
N/A
Earnings
-3.96
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6.66K
Current Ratio
56.10
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-21.62M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-25.88
Shares Held By Institutions
376M
Shares Outstanding - Current
6.68M
Total Liabilities
2.64M
Total Volume MTD
N/A
Value
1
Gain YTD
221.727
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
MNPR
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
View AI-Driven Trading for MNPR
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company, which engages in building a drug development pipeline of oncology therapeutics in late preclinical and clinical development stages

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1000 Skokie Boulevard
Phone
+1 847 388-0349
Employees
10
Web
https://www.monopartx.com